Search Results
Sep 03, 2026, 08:55 ET AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
Inc. (Nasdaq: TEM), Schrödinger, Inc. (Nasdaq: SDGR), Twist Bioscience Corporation (Nasdaq: TWST), Absci Corporation (Nasdaq: ABSI).Forecasters size the category differently but point the same direction. Grand View Research estimated the same market at approximately $1.49
More news about: Equity Insider
Jul 24, 2026, 09:10 ET A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
broader AI-drug-discovery field is drawing intense investor attention, with Recursion Pharmaceuticals (NASDAQ: RXRX), Absci (NASDAQ: ABSI), Tempus AI (NASDAQ: TEM), and NVIDIA (NASDAQ: NVDA) all central to how AI is reshaping the search for new medicines.A First Public
More news about: American News Group
Jul 15, 2026, 08:45 ET As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
pursuing the same idea are getting a second look. All performance figures below are as of mid-July 2026 and will change.Absci (Nasdaq: ABSI) is the closest thematic analog to MindWalk, and the connection is direct: MindWalk CEO Dr. Jennifer Bath appeared alongside Absci on an industry panel
More news about: Equity Insider
Jul 06, 2026, 08:55 ET As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
advancing amid broader activity in AI-enabled life sciences, a landscape that includes public names investors track such as Absci (NASDAQ: ABSI), Certara (NASDAQ: CERT), AstraZeneca (NASDAQ: AZN), and NVIDIA (NASDAQ: NVDA), each distinct, and none a proxy for MindWalk.Patenting
More news about: USA News Group
Jun 16, 2026, 08:45 ET The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
MindWalk Holdings Corp. (NASDAQ: HYFT) joins a virtual investor panel hosted by research firm Jones — alongside generative-biology company Absci (NASDAQ: ABSI) and a leading AI compute provider — titled "Partnering to Power the New Era of Drug Discovery." The panel is a small event, but it sits on top of one
More news about: Equity Insider
Dec 12, 2025, 10:15 ET AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave
complex patterns of their own daily health. These developments position Amazon.com, Inc. (NASDAQ: AMZN) company, Absci Corporation (NASDAQ: ABSI), Certara, Inc. (NASDAQ: CERT), and SOPHiA GENETICS SA (NASDAQ: SOPH as leaders capturing the transformation. Alongside these developments
More news about: Equity Insider